Intellia Therapeutics Inc buy Oppenheimer Holdings Inc.
Start price
13.11.23
/
50%
€22.25
Target price
13.11.24
€65.39
Performance (%)
-30.31%
End price
14.11.24
€15.51
Summary
This prediction ended on 14.11.24 with a price of €15.51. Massive losses of -30.31% were the result for the BUY prediction by Oppenheimer_Holdings. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 10.243% | 10.243% | 99.623% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $80.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Oppenheimer_Holdings for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.72
13.01.25
13.01.25
€39.21
13.01.26
13.01.26
4.78%
14.01.26
14.01.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€16.19
11.11.24
11.11.24
€56.29
11.11.25
11.11.25
-46.53%
12.11.25
12.11.25